Article
Multifunctional CRISPR/Cas9 with engineered immunosilenced human T cell epitopes
2018-07-02
Abstract excerpt
The application of Cas9 for genetic and epigenetic therapies in humans raises concerns over immunogenicity of this foreign protein. We report pre-existing human CD8+ T cell immunity to Streptococcus pyogenes Cas9 in the majority of healthy individuals screened. In a proof-of-principle study, we demonstrate that Cas9 protein can be modified to eliminate immunodominant epitopes through targeted mutation while prese...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 71d9fad9-8722-5b7a-90df-a2e75cdba66b
- DOI
- 10.1101/360198
